NHS Surrey Commissions Risk Stratification Tool from Docobo Ltd to Reduce Unplanned Admissions

Innovative technology developed by UK company Docobo Ltd, will support NHS Surrey in their initiatives to manage patients at home and reduce hospital admissions. NHS Surrey has commissioned Docobo Ltd to supply its new risk stratification tool, ArtemusICS™, that will enable GP practices in Surrey to better target their resources to deliver better outcomes for the 1.2 million people living in Surrey.

The tool takes patient data from both Primary and Secondary care and, through detailed analysis, will identify patients at risk of requiring future healthcare resources and who would likely benefit from a specific Long Term Condition intervention. The data is presented in a convenient 'dashboard' format so that information can be easily accessed via secure web access by authorised staff at GP practices. Data can be examined based on groups of patients, such as by practice or locality, or by clinical condition. Each patient is allocated a 'risk score' which predicts their risk of a hospital admission in the next year. Their GP can view this data and use it to direct their resources more effectively. This enables them toprovide more targeted personalised care and will help to identify and treat health problems earlier. Furthermore, the patients' risk scores can be monitored regularly to examine the effect effectiveness of treatments and interventions.

"We chose the ArtemusICS tool because it enables clinicians to target patients who would benefit from greater intervention, helping to reduce unplanned hospital admissions, which can be very distressing. Using this tool helps clinicians achieve the best possible outcomes for their patients and it also enables them to allocate their resources to best effect," said Christine Ratcliffe, Associate Director of IT Programmes, NHS Surrey. "The tool creates dashboards, which are easy to access, and give clinicians valuable insight into primary and seconday care data, helping them identify those most at risk and enabling them to tailor care to meet their needs. Docobo have worked with us to develop the tool to meet our requirements, and have delivered a quality product that is already making a real difference to GPs."

"Docobo is proud that our ArtemusICS system has been selected by NHS Surrey," said Adrian Flowerday, Managing Director, Docobo Ltd. "We are particularly delighted to have had the opportunity to work closely with Surrey to develop this tool to precisely fit their needs and we look forward to working with the GP practices in Surrey to roll this out."

About Docobo Ltd
Docobo Ltd is a UK medical device company that supplies eHealth solutions to enable Community Care and improve the quality of life of patients, carers and clinicians. More than 40 PCTs and Trusts in the UK and several international healthcare organisations are currently using doc@HOME Telehealth to support their patients.

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...